PT  - JOURNAL ARTICLE
AU  - Zolezzi, Monica
TI  - Methylphenidate. An update on extended-release formulations
DP  - 2007 Jan 01
TA  - Neurosciences Journal
PG  - 3--7
VI  - 12
IP  - 1
4099  - http://nsj.org.sa/content/12/1/3.short
4100  - http://nsj.org.sa/content/12/1/3.full
SO  - Neurosciences (Riyadh)2007 Jan 01; 12
AB  - Methylphenidate remains the mainstay of pharmacological management in attention deficit hyperactivity disorder (ADHD). Despite having been available for over half a century, methylphenidates original formulation has been modified with the main purpose of extending its duration of action. This article will present a brief review of how these new formulations vary and how these should be selected, considering the evidence available on their effectiveness and on the individual needs of the patient.